Clinical Trials Logo
  1. Home
  2. Port Wine Stain
  3. NCT00830466

A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.

Port Wine Stain Clinical Trial

Official title:
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.

Clinical Trial Summary

The researchers want to collect data on safety and efficacy of combined pulsed dye laser and rapamycin to improve fading/blanching of port wine stain birthmarks as compared to pulsed dye laser alone, which is the current standard of care. This single center pilot and feasibility study will have a target enrollment of 40 port wine stain subjects at the Beckman Laser Institute and Medical Clinic, University of California, Irvine.

Clinical Trial Description

The study will offer two different approaches to the treatment of port wine stain birthmarks. Study Group Number 1: Port wine stain treated by the pulsed dye laser alone, which is the current standard of care: 20 subjects. Study Group Number 2: Port wine stain treated by combined pulsed dye laser and rapamycin: 20 subjects. The researchers want to collect data on safety and efficacy of combined pulsed dye laser and rapamycin to improve fading/blanching of port wine stain birthmarks as compared to pulsed dye laser alone, which is the current standard of care. Twenty subjects will have their entire port wine stain birthmark treated by pulsed dye laser alone. Twenty subjects will have their entire port wine stain birthmark treated by combined pulsed dye laser and rapamycin, which is a drug that prevents the formation of blood vessels in the skin. Safety will be evaluated by searching for any local effects such as injury to the skin or systemic effects such as abnormal blood and/or urine studies. Efficacy will be determined by objectively measuring and comparing the port wine stain fading/blanching responses for the two study groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00830466
Study type Interventional
Source University of California, Irvine
Contact
Status Completed
Phase Phase 1
Start date December 2008
Completion date January 2016
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT01438047 - Optical Frequency Domain Imaging (OFDI) in Dermatology N/A
Terminated NCT00782483 - Personalized Interactive Laser Therapy of Port Wine Stain N/A
Completed NCT03948997 - The Role of Angiogenesis-related Pathways in the Development of Port Wine Stains N/A
Completed NCT01364857 - French National Cohort of Children With Port Wine Stain N/A
Withdrawn NCT00969397 - Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks Phase 1/Phase 2
Completed NCT00800722 - A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks. Phase 1
Completed NCT00585247 - Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks N/A
Active, not recruiting NCT00247299 - Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform N/A
Completed NCT00580736 - Optical Clearing of the Skin in Conjunction With Laser Treatments Phase 1
Completed NCT00540566 - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Withdrawn NCT02035319 - Effect of Laser Treatment on Capillary Malformations N/A
Withdrawn NCT01166919 - Pilot Study on the Use of the Matrix Radiofrequencyfor Treatment of Port Wine Stain Birthmarks Phase 1
Completed NCT00540371 - Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
Completed NCT01333553 - Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
Withdrawn NCT00580944 - Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks Phase 1